Distinct Molecular Signatures for Subsets of Patients With CLE Distinct Molecular Signatures for Subsets of Patients With CLE

The findings of this study support a diverse molecular profile in cutaneous lupus erythematosus, opening the door for targeted therapies for different subsets of patients with the disease.The British Journal of Dermatology

Source: Medscape Today Headlines - October 20, 2021 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news